IP Library Granted Patent US 11,331,305
Granted Patent B2
US 11,331,305 · App. 16/709,838 · Granted May 17, 2022

Peptides for skin rejuvenation and methods of using the same

Inventor: Frank Dreher (San Francisco, CA)
Assignee: ANTEIS SA
A61K31/4172A61K8/4946A61K8/64A61K9/0014A61K9/0019A61K38/05A61K38/06A61K38/07A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,331,305
App. No.
16/709,838
Granted
May 17, 2022
Kind
B2
Abstract

The invention provides compositions for stimulating the formation of one or more extracellular matrix components that contain a lipoaminoacid derivative of the tripeptide carnosine such as N-Octanoyl Carnosine. Also provided are compositions containing N-Octanoyl Carnosine in combination with selected tripeptide and/or tetrapeptides as well as pharmaceutical and/or cosmetic compositions containing such compositions. The invention further provides methods of using the compositions and compositions of the invention to treat, alleviate, and/or ameliorate a symptom, condition, disorder, or disease of the skin or mucosa, wherein the symptom, condition, disorder, or disease is associated with changes in extracellular matrix components.

Claims (19)

1. A method of improving or rejuvenating the appearance of skin in a patient in need thereof comprising administering an effective amount of a composition for stimulating the formation of collagen III in skin or mucosa to the patient, wherein the composition comprises N-octanoyl carnosine and N-palmitoyl-GHK and one or more carriers or excipients suitable for topical administration or subcutaneous administration, and wherein the composition stimulates the formation of collagen III to a higher degree than the formation of collagen I.

2. The method of claim 1 , wherein the method results in improving the appearance of aged skin.

3. The method of claim 1 , wherein the composition is administered to the patient in the form of a cosmetic, a personal care product, a feminine care product, a hygiene product, a dermatology product, a pharmaceutical preparation, a medicament, or any combination thereof.

4. The method of claim 1 , wherein the composition is administered topically to the skin or mucosa of the patient.

5. The method of claim 1 , wherein the composition is administered subcutaneously to the patient.

6. The method of claim 1 , wherein the composition stimulates the formation of collagen Ill by at least 120% and the formation of collagen I by at least 38%.

7. The method of claim 1 , wherein the composition is administered to the face of the patient.

8. The method of claim 1 , wherein the composition further comprises the tetra-peptide GEKG (SEQ ID NO:1), and wherein the weight ratio of N-octanoyl carnosine:N-palmitoyl-GHK:GEKG (SEQ ID NO:1) is 4:1:5.

9. The method of claim 8 , wherein the composition further stimulates the formation of hyaluronic acid.

10. The method of claim 9 , wherein the combination of active ingredients N-octanoyl carnosine, N-palmitoyl-GHK, and GEKG (SEQ ID NO:1) stimulates the production of extracellular matrix components in skin or epithelial cells to a greater degree than any one or two of the active ingredients alone.

11. The method of claim 1 , wherein the composition comprises between about 0.0001% to 10% per weight of N-octanoyl carnosine.

12. The method of claim 1 , wherein the composition comprises about 0.004% per weight of N-octanoyl carnosine; and further comprises about 0.001% per weight of N-palmitoyl-GHK, and about 0.005% per weight of GEKG (SEQ ID NO:1), and one or more acceptable carriers or excipients suitable for topical application in humans on skin, aged skin, damaged skin, skin after cosmetic and dermatological procedures, wounded skin, atrophic skin, atrophic mucosa, atrophic vulva, and/or atrophic vagina.

13. The method of claim 1 , wherein the composition is a pharmaceutical composition and further comprises one or more pharmaceutically acceptable carriers.

14. The method of claim 1 , wherein the composition is a cosmetic composition and further comprises one or more cosmetically acceptable carriers.

15. The method of claim 1 , wherein the composition further stimulates the formation of elastin, laminin, hyaluronan synthase 2, fibrillin 1, and/or heparan sulfate proteoglycan.

16. The method of claim 1 , wherein the method further results in one or more of the following: improving the state of aged skin, reducing the signs of aging, reducing scarring of damaged skin, restoring damaged skin, enhancing the restoration of skin after cosmetic and dermatological procedures, restoring aging vulvar vaginal tissue, reducing scarring of damaged skin, or restoring damaged skin.

17. The method of claim 1 , wherein the composition is administered to

a) one or more areas of skin selected from the group consisting of neck, neckline, decollete, scalp, hand, palm, arm, leg, foot, sole, chest, breast, back, abdomen, buttock, vulva, penis, scrotum, and anus; or

b) one or more mucosal areas selected from the group consisting of eye, mouth, nose, nipples, vulva, vagina, vaginal introitus, penis, and rectum.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Jan 26, 2022
From: NEOCUTIS SA; ANTEIS SA
To: ANTEIS SA
Reel/Frame 058770/0001 →
MERGER Recorded Jan 26, 2022
From: NEOCUTIS SA
To: ANTEIS SA
Reel/Frame 058854/0766 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 041940 FRAME: 0065. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER . Recorded Jan 26, 2022
From: NEOCUTIS SA
To: ANTEIS SA
Reel/Frame 058854/0959 →
Continuity (4)
Division 15164686 · May 25, 2016
Division 14202418 · Mar 10, 2014
Provisional Application 61779601 · Mar 13, 2013
Related Publication 20200093799A1 · Mar 26, 2020
Cited By (1)
US 12,467,171